Read More Pharma Industry News Pfizer thought it secured Metsera—then Novo Nordisk crashed the party with a bigger bid Novo Nordisk just challenged Pfizer’s Metsera deal with a $9B rival bid. Find out how this could reshape the weight-loss drug landscape in 2025. bySrinathOctober 31, 2025